Golgi protein 73 (GP73) levels are elevated in patients with HCC, and GP73 possesses superior sensitivity and specificity to AFP in predicting early-stage HCC; it is also a promising therapeutic target for HCC. The gene discussed is GOLM1; the disease is hepatocellular carcinoma.